HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
Recruiting · NCT07459673 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-08-20 | NCT07459673 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | United States | 46 |
| Memorial Sloan Kettering at Bergen (Limited Protocol Activities) | Montvale | United States | 12 |
| Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) | Middletown | United States | 11 |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Uniondale | United States | 13 |
| Memorial Sloan Kettering at Westchester (Limited Protocol Activities) | Harrison | United States | 12 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York | United States | 47 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Commack | United States | 21 |